Showing 16,141 - 16,151 results of 16,151 for search '(( 59 0 decrease ) OR ( 50 ((((we decrease) OR (mean decrease))) OR (nn decrease)) ))', query time: 0.60s Refine Results
  1. 16141

    S1 Data - by Dénes Pauka (16955686)

    Published 2023
    “…Comparing the histological groups by the measured parameters (<i>F</i><sub>max</sub>, <i>L</i><sub>max</sub>, <i>F</i><sub>break</sub>, <i>L</i><sub>break</sub>) showed a significant difference in the means (p<0.001, p = 0.003, p<0.001 respectively). …”
  2. 16142
  3. 16143
  4. 16144

    Silencing of IRE1 but not XBP1 downregulates IRF4. by Ioanna Oikonomidi (21071942)

    Published 2025
    “…L363 shIRE1 Cl.C versus L363 shXBP1 Cl.N cells were treated with Dox (0.2 μg/mL) for the indicated time and analyzed by RT-qPCR for levels of <i>ERN1</i>, <i>IRF4</i> and <i>XBP1s</i>. …”
  5. 16145

    Phenotypic characterization of <i>CsIVP</i>-RNAi transgenic plants. by Shuangshuang Yan (798064)

    Published 2020
    “…(I) Reduced mature fruit length and decreased seed viability in the <i>CsIVP</i>-RNAi lines. …”
  6. 16146

    Data_Sheet_1_The effect of Ba Duan Jin exercise intervention on cardiovascular disease: a meta-analysis of randomized controlled trials.PDF by Jiali Chen (5696)

    Published 2024
    “…Subgroup analyses reveal that Ba Duan Jin exercise therapy decreases SBP (MD = −4.05, 95% CI = −6.84 to −1.26, p < 0.01) and DBP (MD = −3.21, 95% CI = −5.22 to −1.20, p < 0.01) levels in patients with essential hypertension, significantly reduces serum TC (MD = −0.78, 95% CI = −1.06 to −0.50, p < 0.01), TG (MD = −0.78, 95% CI = −0.93 to −0.62, p < 0.01), and LDL-C (MD = −0.76, 95% CI = −0.92 to −0.60, p < 0.01) levels in patients with hyperlipidemia, increases HDL-C (MD = 0.32, 95% CI = 0.14–0.51, p < 0.01) levels, and produces beneficial effects on cardiovascular function. …”
  7. 16147
  8. 16148
  9. 16149

    PDLB - Balance Sheet by Nguyen Linh (19516642)

    Published 2024
    “…</p><p><br></p><p dir="ltr">ECIP capital: PDLB received $225M of ECIP capital, and the regulators assigned them the lowest possible dividend (0.5%) on this capital for the first year of payments (announced in June). If we assume PDLB continues to pay 0.5% on this preferred and they have a cost of preferred equity of 10%, then we can calculate the value of this $225M liability as just $11M, with the rest a write-up to equity.…”
  10. 16150
  11. 16151

    Single-cell-resolution analysis of RPE flatmounts revealed only minor changes to cellular morphology. by Viola Kretschmer (485828)

    Published 2023
    “…P29: <i>Ift20</i><sup><i>+/+</i></sup><i>;Tyrp2-Cre</i> 8.88, <i>Ift20</i><sup><i>null</i></sup><i>;Tyrp2-Cre</i> 8.86. 3m: <i>Ift20</i><sup><i>+/+</i></sup><i>;Tyrp2-Cre</i> 8.60, <i>Ift20</i><sup><i>null</i></sup><i>;Tyrp2-Cre</i> 8.64 μm<sup>2</sup>. n numbers P11: <i>Ift20</i><sup><i>+/+</i></sup><i>;Tyrp2-Cre</i> (7 flat mounts, 163,530 cells); <i>Ift20</i><sup><i>null</i></sup><i>;Tyrp2-Cre</i> (14 flat mounts 295,059 cells), P29: <i>Ift20</i><sup><i>+/+</i></sup><i>;Tyrp2-Cre</i> (11 flat mounts, 274,428 cells)<i>; Ift20</i><sup><i>null</i></sup><i>;Tyrp2-Cre</i> (9 flat mounts, 227,064 cells), 3m: <i>Ift20</i><sup><i>+/+</i></sup><i>;Tyrp2-Cre</i> (13 flat mounts, 510,473 cells)<i>; Ift20</i><sup><i>null</i></sup><i>;Tyrp2-Cre</i> (18 flat mounts 675,748 cells). Significance levels: >0.05 not significant (ns), <0.05 *, <0.01 **, <0.001 ***. …”